Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-10-08

AUTHORS

Laura Bica, Jodi Meyerowitz, Sarah J. Parker, Aphrodite Caragounis, Tai Du, Brett M. Paterson, Kevin J. Barnham, Peter J. Crouch, Anthony R. White, Paul S. Donnelly

ABSTRACT

Brain tumors such as neuroblastomas and gliomas are often refractory to current treatments. Development of metal-based drugs may offer an alternative approach due to the ability to deliver radionuclides or cytotoxic metals to the tumor. Previous studies have shown that diacetyl-bis(N(4)-methylthiosemicarbazonato)-copper(II) (CuII(atsm)) can selectively target hypoxic tumors and this feature has been utilized for development of imaging and radiotherapy. However, we have recently shown that glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) (CuII(gtsm)) can target the brain in animal models of neurodegeneration. Unlike CuII(atsm), CuII(gtsm) is able to release Cu intracellularly under normoxic conditions. Glyoxal-bis(thiosemicarbazones) have reported anticancer effects but little is known about the cellular mechanisms involved. Therefore, in this study, we used protein microarray analysis to investigate the effect of CuII(gtsm) on neuroblastoma cell growth in vitro. Treatment of the human neuroblastoma cell line BE(2)-M17, resulted in cell cycle arrest as assessed by fluorescent activated cell sorting (FACS) analysis. Rapidly arrested growth was not associated with onset of apoptosis. Instead, protein microarray analysis revealed that CuII(gtsm) rapidly and potently reduced cyclin D1 expression, while increasing Kip2 expression. Other changes observed were decreased Cdk7 expression and activation of CHK2. These changes may be associated with the cell cycle arrest. We also observed a potent decrease of total and phosphorylated insulin-like growth factor receptor (IGF-IR) by CuII(gtsm) which is associated with modulation of cyclin D1 expression. Our studies reveal important insights into the potential anticancer activity of CuII(gtsm). Further studies are needed to examine the therapeutic potential of CuII(gtsm) and other bis(thiosemicarbazonato) metal complexes as metallo-drugs for treatment of systemic or brain tumors. More... »

PAGES

117-133

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10534-010-9380-7

DOI

http://dx.doi.org/10.1007/s10534-010-9380-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026819361

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20931265


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Copper", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Screening Assays, Antitumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Structure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuroblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organometallic Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stereoisomerism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiosemicarbazones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.415325.4", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bica", 
        "givenName": "Laura", 
        "id": "sg:person.01303533017.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303533017.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.415325.4", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meyerowitz", 
        "givenName": "Jodi", 
        "id": "sg:person.0603416005.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603416005.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.415325.4", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parker", 
        "givenName": "Sarah J.", 
        "id": "sg:person.01327022105.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327022105.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.415325.4", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caragounis", 
        "givenName": "Aphrodite", 
        "id": "sg:person.01326465214.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326465214.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.415325.4", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Du", 
        "givenName": "Tai", 
        "id": "sg:person.01056145171.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056145171.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The School of Chemistry, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1008.9", 
          "name": [
            "Bio21 Institute of Molecular Science and Biotechnology, Parkville, 3052, Melbourne, VIC, Australia", 
            "The School of Chemistry, The University of Melbourne, 3010, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paterson", 
        "givenName": "Brett M.", 
        "id": "sg:person.01207027214.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207027214.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bio21 Institute of Molecular Science and Biotechnology, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
            "Bio21 Institute of Molecular Science and Biotechnology, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barnham", 
        "givenName": "Kevin J.", 
        "id": "sg:person.01323364351.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323364351.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.415325.4", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crouch", 
        "givenName": "Peter J.", 
        "id": "sg:person.0643471176.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643471176.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.415325.4", 
          "name": [
            "Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
            "The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "White", 
        "givenName": "Anthony R.", 
        "id": "sg:person.0607257105.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607257105.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The School of Chemistry, The University of Melbourne, 3010, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1008.9", 
          "name": [
            "Bio21 Institute of Molecular Science and Biotechnology, Parkville, 3052, Melbourne, VIC, Australia", 
            "The School of Chemistry, The University of Melbourne, 3010, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Donnelly", 
        "givenName": "Paul S.", 
        "id": "sg:person.01264550005.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264550005.46"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/bcr1322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017093322", 
          "https://doi.org/10.1186/bcr1322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/210104b0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021289526", 
          "https://doi.org/10.1038/210104b0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006958018049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014844291", 
          "https://doi.org/10.1023/a:1006958018049"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002590050283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037179736", 
          "https://doi.org/10.1007/s002590050283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050293306", 
          "https://doi.org/10.1038/sj.bjc.6605141"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s007750100291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008086577", 
          "https://doi.org/10.1007/s007750100291"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-10-08", 
    "datePublishedReg": "2010-10-08", 
    "description": "Brain tumors such as neuroblastomas and gliomas are often refractory to current treatments. Development of metal-based drugs may offer an alternative approach due to the ability to deliver radionuclides or cytotoxic metals to the tumor. Previous studies have shown that diacetyl-bis(N(4)-methylthiosemicarbazonato)-copper(II) (CuII(atsm)) can selectively target hypoxic tumors and this feature has been utilized for development of imaging and radiotherapy. However, we have recently shown that glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) (CuII(gtsm)) can target the brain in animal models of neurodegeneration. Unlike CuII(atsm), CuII(gtsm) is able to release Cu intracellularly under normoxic conditions. Glyoxal-bis(thiosemicarbazones) have reported anticancer effects but little is known about the cellular mechanisms involved. Therefore, in this study, we used protein microarray analysis to investigate the effect of CuII(gtsm) on neuroblastoma cell growth in vitro. Treatment of the human neuroblastoma cell line BE(2)-M17, resulted in cell cycle arrest as assessed by fluorescent activated cell sorting (FACS) analysis. Rapidly arrested growth was not associated with onset of apoptosis. Instead, protein microarray analysis revealed that CuII(gtsm) rapidly and potently reduced cyclin D1 expression, while increasing Kip2 expression. Other changes observed were decreased Cdk7 expression and activation of CHK2. These changes may be associated with the cell cycle arrest. We also observed a potent decrease of total and phosphorylated insulin-like growth factor receptor (IGF-IR) by CuII(gtsm) which is associated with modulation of cyclin D1 expression. Our studies reveal important insights into the potential anticancer activity of CuII(gtsm). Further studies are needed to examine the therapeutic potential of CuII(gtsm) and other bis(thiosemicarbazonato) metal complexes as metallo-drugs for treatment of systemic or brain tumors.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10534-010-9380-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1102420", 
        "issn": [
          "0966-0844", 
          "1572-8773"
        ], 
        "name": "BioMetals", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "keywords": [
      "cell cycle arrest", 
      "cyclin D1 expression", 
      "brain tumors", 
      "protein microarray analysis", 
      "cycle arrest", 
      "D1 expression", 
      "insulin-like growth factor receptor", 
      "human neuroblastoma cell line", 
      "neuroblastoma cell growth", 
      "cultured neuroblastoma cells", 
      "neuroblastoma cell lines", 
      "microarray analysis", 
      "growth factor receptor", 
      "cell sorting (FACS) analysis", 
      "current treatment", 
      "potent decrease", 
      "animal models", 
      "therapeutic potential", 
      "tumors", 
      "anticancer effects", 
      "CDK7 expression", 
      "neuroblastoma cells", 
      "normoxic conditions", 
      "factor receptor", 
      "cellular mechanisms", 
      "hypoxic tumors", 
      "Further studies", 
      "potential anticancer activity", 
      "cell lines", 
      "treatment", 
      "KIP2 expression", 
      "arrest", 
      "development of imaging", 
      "anticancer activity", 
      "cell growth", 
      "expression", 
      "onset of apoptosis", 
      "previous studies", 
      "radiotherapy", 
      "neuroblastoma", 
      "study", 
      "gliomas", 
      "brain", 
      "neurodegeneration", 
      "receptors", 
      "drugs", 
      "total", 
      "onset", 
      "apoptosis", 
      "activation", 
      "imaging", 
      "effect", 
      "activation of Chk2", 
      "changes", 
      "cells", 
      "modulation", 
      "decrease", 
      "important insights", 
      "development", 
      "activity", 
      "analysis", 
      "mechanism", 
      "growth", 
      "alternative approach", 
      "ability", 
      "Chk2", 
      "lines", 
      "metal-based drugs", 
      "potential", 
      "features", 
      "fluorescent", 
      "radionuclides", 
      "complexes", 
      "conditions", 
      "insights", 
      "glyoxal", 
      "diacetyl", 
      "model", 
      "approach", 
      "metals", 
      "Cu", 
      "metal complexes", 
      "sorting (FACS) analysis", 
      "phosphorylated insulin-like growth factor receptor"
    ], 
    "name": "Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex", 
    "pagination": "117-133", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026819361"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10534-010-9380-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20931265"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10534-010-9380-7", 
      "https://app.dimensions.ai/details/publication/pub.1026819361"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_514.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10534-010-9380-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10534-010-9380-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10534-010-9380-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10534-010-9380-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10534-010-9380-7'


 

This table displays all metadata directly associated to this object as RDF triples.

300 TRIPLES      22 PREDICATES      130 URIs      116 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10534-010-9380-7 schema:about N05fa8def53e9476fa37a9e65ea7e28ca
2 N19ab1e4b03814c1287c3f869fea56177
3 N28611bc0516f4795a3abfa304f301578
4 N2f472990fede42f1a2b2768ce4f5dfb7
5 N3ad51f18a19947a7ad24ee1ff367646a
6 N58b8ca7d219b4b81a382f13a63fc1770
7 N5e187468a582456d961557c5405e7b60
8 N63446d6c82d24f33ae0a48332f83bbc6
9 N8eedcd55978d47e5a9db6ea290697cfc
10 Nafcd8df625534326b69917953093730f
11 Nc67300ab6d94407990e83383b158621b
12 Ncd0148c552bd4135aac8210fd44e3997
13 Nd9f90ff8a5bb43c499687f8195999222
14 Ne65899f2df11480c89819b351a6eca27
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N858bd12b79f047199a46a6a55f03eb4b
18 schema:citation sg:pub.10.1007/s002590050283
19 sg:pub.10.1007/s007750100291
20 sg:pub.10.1023/a:1006958018049
21 sg:pub.10.1038/210104b0
22 sg:pub.10.1038/sj.bjc.6605141
23 sg:pub.10.1186/bcr1322
24 schema:datePublished 2010-10-08
25 schema:datePublishedReg 2010-10-08
26 schema:description Brain tumors such as neuroblastomas and gliomas are often refractory to current treatments. Development of metal-based drugs may offer an alternative approach due to the ability to deliver radionuclides or cytotoxic metals to the tumor. Previous studies have shown that diacetyl-bis(N(4)-methylthiosemicarbazonato)-copper(II) (CuII(atsm)) can selectively target hypoxic tumors and this feature has been utilized for development of imaging and radiotherapy. However, we have recently shown that glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) (CuII(gtsm)) can target the brain in animal models of neurodegeneration. Unlike CuII(atsm), CuII(gtsm) is able to release Cu intracellularly under normoxic conditions. Glyoxal-bis(thiosemicarbazones) have reported anticancer effects but little is known about the cellular mechanisms involved. Therefore, in this study, we used protein microarray analysis to investigate the effect of CuII(gtsm) on neuroblastoma cell growth in vitro. Treatment of the human neuroblastoma cell line BE(2)-M17, resulted in cell cycle arrest as assessed by fluorescent activated cell sorting (FACS) analysis. Rapidly arrested growth was not associated with onset of apoptosis. Instead, protein microarray analysis revealed that CuII(gtsm) rapidly and potently reduced cyclin D1 expression, while increasing Kip2 expression. Other changes observed were decreased Cdk7 expression and activation of CHK2. These changes may be associated with the cell cycle arrest. We also observed a potent decrease of total and phosphorylated insulin-like growth factor receptor (IGF-IR) by CuII(gtsm) which is associated with modulation of cyclin D1 expression. Our studies reveal important insights into the potential anticancer activity of CuII(gtsm). Further studies are needed to examine the therapeutic potential of CuII(gtsm) and other bis(thiosemicarbazonato) metal complexes as metallo-drugs for treatment of systemic or brain tumors.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf Nbc03d4fffb7942cd97ea00298dd478ad
31 Nf09425ae4e27465f8dc626e64feb5882
32 sg:journal.1102420
33 schema:keywords CDK7 expression
34 Chk2
35 Cu
36 D1 expression
37 Further studies
38 KIP2 expression
39 ability
40 activation
41 activation of Chk2
42 activity
43 alternative approach
44 analysis
45 animal models
46 anticancer activity
47 anticancer effects
48 apoptosis
49 approach
50 arrest
51 brain
52 brain tumors
53 cell cycle arrest
54 cell growth
55 cell lines
56 cell sorting (FACS) analysis
57 cells
58 cellular mechanisms
59 changes
60 complexes
61 conditions
62 cultured neuroblastoma cells
63 current treatment
64 cycle arrest
65 cyclin D1 expression
66 decrease
67 development
68 development of imaging
69 diacetyl
70 drugs
71 effect
72 expression
73 factor receptor
74 features
75 fluorescent
76 gliomas
77 glyoxal
78 growth
79 growth factor receptor
80 human neuroblastoma cell line
81 hypoxic tumors
82 imaging
83 important insights
84 insights
85 insulin-like growth factor receptor
86 lines
87 mechanism
88 metal complexes
89 metal-based drugs
90 metals
91 microarray analysis
92 model
93 modulation
94 neuroblastoma
95 neuroblastoma cell growth
96 neuroblastoma cell lines
97 neuroblastoma cells
98 neurodegeneration
99 normoxic conditions
100 onset
101 onset of apoptosis
102 phosphorylated insulin-like growth factor receptor
103 potent decrease
104 potential
105 potential anticancer activity
106 previous studies
107 protein microarray analysis
108 radionuclides
109 radiotherapy
110 receptors
111 sorting (FACS) analysis
112 study
113 therapeutic potential
114 total
115 treatment
116 tumors
117 schema:name Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex
118 schema:pagination 117-133
119 schema:productId N0827f30d054446b6ae4d442e7a09197a
120 N8d03a33a48314225a9d1f176bd7a4a8c
121 Nf589d7818cc14d36bb3fd712f5c98476
122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026819361
123 https://doi.org/10.1007/s10534-010-9380-7
124 schema:sdDatePublished 2022-01-01T18:23
125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
126 schema:sdPublisher N613a42e5df2e4d8ba8bbfb0e8d0b0ba1
127 schema:url https://doi.org/10.1007/s10534-010-9380-7
128 sgo:license sg:explorer/license/
129 sgo:sdDataset articles
130 rdf:type schema:ScholarlyArticle
131 N05fa8def53e9476fa37a9e65ea7e28ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Cell Cycle
133 rdf:type schema:DefinedTerm
134 N0827f30d054446b6ae4d442e7a09197a schema:name doi
135 schema:value 10.1007/s10534-010-9380-7
136 rdf:type schema:PropertyValue
137 N19ab1e4b03814c1287c3f869fea56177 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Brain Neoplasms
139 rdf:type schema:DefinedTerm
140 N28611bc0516f4795a3abfa304f301578 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Tumor Cells, Cultured
142 rdf:type schema:DefinedTerm
143 N2f472990fede42f1a2b2768ce4f5dfb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Thiosemicarbazones
145 rdf:type schema:DefinedTerm
146 N3ad51f18a19947a7ad24ee1ff367646a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Neuroblastoma
148 rdf:type schema:DefinedTerm
149 N3bcd2402147f413c91705b52a14f49ec rdf:first sg:person.01327022105.12
150 rdf:rest N41e50dab7afa493c90066e39863e8671
151 N41e50dab7afa493c90066e39863e8671 rdf:first sg:person.01326465214.43
152 rdf:rest Ndeb29c9da3d04d0f8f9812ff7a2583f8
153 N58b8ca7d219b4b81a382f13a63fc1770 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Organometallic Compounds
155 rdf:type schema:DefinedTerm
156 N5e187468a582456d961557c5405e7b60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Drug Screening Assays, Antitumor
158 rdf:type schema:DefinedTerm
159 N5fc8152effba4eb89583bf6f1f3a0ae6 rdf:first sg:person.0643471176.25
160 rdf:rest N69b306a798d54876ad634b0b9a27eddf
161 N613a42e5df2e4d8ba8bbfb0e8d0b0ba1 schema:name Springer Nature - SN SciGraph project
162 rdf:type schema:Organization
163 N63446d6c82d24f33ae0a48332f83bbc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Flow Cytometry
165 rdf:type schema:DefinedTerm
166 N639fce389c4345e6abd829601db03c15 rdf:first sg:person.01264550005.46
167 rdf:rest rdf:nil
168 N69b306a798d54876ad634b0b9a27eddf rdf:first sg:person.0607257105.16
169 rdf:rest N639fce389c4345e6abd829601db03c15
170 N83b4f96339b744af8b2946810bbb45ae rdf:first sg:person.0603416005.43
171 rdf:rest N3bcd2402147f413c91705b52a14f49ec
172 N858bd12b79f047199a46a6a55f03eb4b rdf:first sg:person.01303533017.06
173 rdf:rest N83b4f96339b744af8b2946810bbb45ae
174 N887e296142eb4ae8ac9f9856c2745c5d rdf:first sg:person.01207027214.71
175 rdf:rest Ncb0ef0cadf5e47668977cbc2b1124c1f
176 N8d03a33a48314225a9d1f176bd7a4a8c schema:name pubmed_id
177 schema:value 20931265
178 rdf:type schema:PropertyValue
179 N8eedcd55978d47e5a9db6ea290697cfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Cell Proliferation
181 rdf:type schema:DefinedTerm
182 Nafcd8df625534326b69917953093730f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Antineoplastic Agents
184 rdf:type schema:DefinedTerm
185 Nbc03d4fffb7942cd97ea00298dd478ad schema:issueNumber 1
186 rdf:type schema:PublicationIssue
187 Nc67300ab6d94407990e83383b158621b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Copper
189 rdf:type schema:DefinedTerm
190 Ncb0ef0cadf5e47668977cbc2b1124c1f rdf:first sg:person.01323364351.51
191 rdf:rest N5fc8152effba4eb89583bf6f1f3a0ae6
192 Ncd0148c552bd4135aac8210fd44e3997 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Molecular Structure
194 rdf:type schema:DefinedTerm
195 Nd9f90ff8a5bb43c499687f8195999222 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Stereoisomerism
197 rdf:type schema:DefinedTerm
198 Ndeb29c9da3d04d0f8f9812ff7a2583f8 rdf:first sg:person.01056145171.18
199 rdf:rest N887e296142eb4ae8ac9f9856c2745c5d
200 Ne65899f2df11480c89819b351a6eca27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Humans
202 rdf:type schema:DefinedTerm
203 Nf09425ae4e27465f8dc626e64feb5882 schema:volumeNumber 24
204 rdf:type schema:PublicationVolume
205 Nf589d7818cc14d36bb3fd712f5c98476 schema:name dimensions_id
206 schema:value pub.1026819361
207 rdf:type schema:PropertyValue
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
212 schema:name Clinical Sciences
213 rdf:type schema:DefinedTerm
214 sg:journal.1102420 schema:issn 0966-0844
215 1572-8773
216 schema:name BioMetals
217 schema:publisher Springer Nature
218 rdf:type schema:Periodical
219 sg:person.01056145171.18 schema:affiliation grid-institutes:grid.415325.4
220 schema:familyName Du
221 schema:givenName Tai
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056145171.18
223 rdf:type schema:Person
224 sg:person.01207027214.71 schema:affiliation grid-institutes:grid.1008.9
225 schema:familyName Paterson
226 schema:givenName Brett M.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207027214.71
228 rdf:type schema:Person
229 sg:person.01264550005.46 schema:affiliation grid-institutes:grid.1008.9
230 schema:familyName Donnelly
231 schema:givenName Paul S.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264550005.46
233 rdf:type schema:Person
234 sg:person.01303533017.06 schema:affiliation grid-institutes:grid.415325.4
235 schema:familyName Bica
236 schema:givenName Laura
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303533017.06
238 rdf:type schema:Person
239 sg:person.01323364351.51 schema:affiliation grid-institutes:None
240 schema:familyName Barnham
241 schema:givenName Kevin J.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323364351.51
243 rdf:type schema:Person
244 sg:person.01326465214.43 schema:affiliation grid-institutes:grid.415325.4
245 schema:familyName Caragounis
246 schema:givenName Aphrodite
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326465214.43
248 rdf:type schema:Person
249 sg:person.01327022105.12 schema:affiliation grid-institutes:grid.415325.4
250 schema:familyName Parker
251 schema:givenName Sarah J.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327022105.12
253 rdf:type schema:Person
254 sg:person.0603416005.43 schema:affiliation grid-institutes:grid.415325.4
255 schema:familyName Meyerowitz
256 schema:givenName Jodi
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603416005.43
258 rdf:type schema:Person
259 sg:person.0607257105.16 schema:affiliation grid-institutes:grid.415325.4
260 schema:familyName White
261 schema:givenName Anthony R.
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607257105.16
263 rdf:type schema:Person
264 sg:person.0643471176.25 schema:affiliation grid-institutes:grid.415325.4
265 schema:familyName Crouch
266 schema:givenName Peter J.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643471176.25
268 rdf:type schema:Person
269 sg:pub.10.1007/s002590050283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037179736
270 https://doi.org/10.1007/s002590050283
271 rdf:type schema:CreativeWork
272 sg:pub.10.1007/s007750100291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008086577
273 https://doi.org/10.1007/s007750100291
274 rdf:type schema:CreativeWork
275 sg:pub.10.1023/a:1006958018049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014844291
276 https://doi.org/10.1023/a:1006958018049
277 rdf:type schema:CreativeWork
278 sg:pub.10.1038/210104b0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021289526
279 https://doi.org/10.1038/210104b0
280 rdf:type schema:CreativeWork
281 sg:pub.10.1038/sj.bjc.6605141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050293306
282 https://doi.org/10.1038/sj.bjc.6605141
283 rdf:type schema:CreativeWork
284 sg:pub.10.1186/bcr1322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017093322
285 https://doi.org/10.1186/bcr1322
286 rdf:type schema:CreativeWork
287 grid-institutes:None schema:alternateName Bio21 Institute of Molecular Science and Biotechnology, Parkville, 3052, Melbourne, VIC, Australia
288 schema:name Bio21 Institute of Molecular Science and Biotechnology, Parkville, 3052, Melbourne, VIC, Australia
289 Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia
290 The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia
291 rdf:type schema:Organization
292 grid-institutes:grid.1008.9 schema:alternateName The School of Chemistry, The University of Melbourne, 3010, Melbourne, VIC, Australia
293 schema:name Bio21 Institute of Molecular Science and Biotechnology, Parkville, 3052, Melbourne, VIC, Australia
294 The School of Chemistry, The University of Melbourne, 3010, Melbourne, VIC, Australia
295 rdf:type schema:Organization
296 grid-institutes:grid.415325.4 schema:alternateName The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia
297 schema:name Department of Pathology, Centre for Neuroscience, The University of Melbourne, 3010, Melbourne, VIC, Australia
298 Department of Pathology, The University of Melbourne, 3010, Melbourne, VIC, Australia
299 The Mental Health Research Institute, Parkville, 3052, Melbourne, VIC, Australia
300 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...